Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published-Ahead-of-Print July 12, 2006, DOI:10.2164/jandrol.106.000349
Journal of Andrology, Vol. 27, No. 6, November/December 2006
Copyright © American Society of Andrology
DOI: 10.2164/jandrol.106.000349

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
27/6/868    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anway, M. D.
Right arrow Articles by Skinner, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anway, M. D.
Right arrow Articles by Skinner, M. K.

Transgenerational Effect of the Endocrine Disruptor Vinclozolin on Male Spermatogenesis

MATTHEW D. ANWAY, MUSHTAQ A. MEMON, MEHMET UZUMCU* AND MICHAEL K. SKINNER

From the Center for Reproductive Biology, School of Molecular Biosciences, Washington State University, Pullman, Washington.

Correspondence to: Michael K. Skinner, Center for Reproductive Biology, School of Molecular Biosciences, Washington State University, Pullman, WA 99164-4231 (e-mail: skinner{at}mail.wsu.edu).


The current study was designed to examine the actions of a model endocrine disruptor on embryonic testis development and male fertility. Pregnant rats (F0) that received a transient embryonic exposure to an environmental endocrine disruptor, vinclozolin, had male offspring (F1) with reduced spermatogenic capacity. The reduced spermatogenetic capacity observed in the F1 male offspring was transmitted to the subsequent generations (F2–F4). The administration of vinclozolin, an androgen receptor antagonist, at 100 mg/kg/day from embryonic day 8–14 (E8–E14) of pregnancy to only the F0 dam resulted in a transgenerational phenotype in the subsequent male offspring in the F1–F4 generations. The litter size and male/female sex ratios were similar in controls and the vinclozolin generations. The average testes/body weight index of the postnatal day 60 (P60) males was not significantly different in the vinclozolin-treated generations compared to the controls. However, the testicular spermatid number, as well as the epididymal sperm number and motility, were significantly reduced in the vinclozolin generations compared to the control animals. Postnatal day 20 (P20) testis from the vinclozolin F2 generation had no morphological abnormalities, but did have an increase in spermatogenic cell apoptosis. Although the P60 testis morphology was predominantly normal, the germ cell apoptosis was significantly increased in the testes cross sections of animals from the vinclozolin generations. The increase in apoptosis was stage-specific in the testis, with tubules at stages IX–XIV having the highest increase in apoptotic germ cells. The tubules at stages I–V also had an increase in apoptotic germ cells compared to the control samples, but tubules at stages VI–VIII had no increase in apoptotic germ cells. An outcross of a vinclozolin generation male with a wild-type female demonstrated that the reduced spermatogenic cell phenotype was transmitted through the male germ line. An outcross with a vinclozolin generation female with a wild-type male had no phenotype. A similar phenotype was observed in outbred Sprague Dawley and inbred Fisher rat strains. Observations demonstrate that a transient exposure at the time of male sex determination to the antiandrogenic endocrine disruptor vinclozolin can induce an apparent epigenetic transgenerational phenotype with reduced spermatogenic capacity.

     Key words: Epigenetic, testis, gametogenesis, male infertility, antiandrogen, apoptosis




This article has been cited by other articles:


Home page
ReproductionHome page
E. E Nilsson, M. D Anway, J. Stanfield, and M. K Skinner
Transgenerational epigenetic effects of the endocrine disruptor vinclozolin on pregnancies and female adult onset disease
Reproduction, May 1, 2008; 135(5): 713 - 721.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. E. Vahter
Interactions between Arsenic-Induced Toxicity and Nutrition in Early Life
J. Nutr., December 1, 2007; 137(12): 2798 - 2804.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. McClusky, C de Jager, and M. Bornman
Stage-Related Increase in the Proportion of Apoptotic Germ Cells and Altered Frequencies of Stages in the Spermatogenic Cycle Following Gestational, Lactational, and Direct Exposure of Male Rats to p-Nonylphenol
Toxicol. Sci., January 1, 2007; 95(1): 249 - 256.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The American Society of Andrology.